CSPC Pharmaceutical Group Limited (CVG) — Strategic Asset Allocation Index
CSPC Pharmaceutical Group Limited (CVG) has a Strategic Asset Allocation Index of 33.9% as of June 2023. Strategic assets (PP&E of €11.36 Billion plus long-term investments of €-) total €11.36 Billion, measured against net assets of €33.51 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See how leveraged is CSPC Pharmaceutical Group Limited's balance sheet to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
CSPC Pharmaceutical Group Limited Strategic Asset Allocation Index (2013–2021)
This chart shows how CSPC Pharmaceutical Group Limited's Strategic Asset Allocation Index has evolved across 9 annual periods from 2013 to 2021. As of June 2023, the index stands at 33.9%, representing strategic assets of €11.36 Billion against net assets of €33.51 Billion EUR. For live market cap and overall valuation, see CSPC Pharmaceutical Group Limited (CVG) market capitalisation.
Annual Strategic Asset Allocation Index for CSPC Pharmaceutical Group Limited (2013–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for CSPC Pharmaceutical Group Limited from 2013 to 2021, covering 9 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See CSPC Pharmaceutical Group Limited book value and equity for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (EUR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 35.6% | €9.56 Billion | €9.56 Billion | €- | €26.83 Billion | ▼ -3.0 pp |
| 2020 | 38.7% | €8.93 Billion | €8.93 Billion | €- | €23.10 Billion | ▼ -8.9 pp |
| 2019 | 47.6% | €9.28 Billion | €9.28 Billion | €- | €19.52 Billion | ▼ -1.5 pp |
| 2018 | 49.0% | €7.60 Billion | €6.69 Billion | €907.43 Million | €15.50 Billion | ▼ -6.0 pp |
| 2017 | 55.1% | €7.09 Billion | €6.66 Billion | €426.72 Million | €12.87 Billion | ▼ -6.2 pp |
| 2016 | 61.2% | €5.59 Billion | €5.42 Billion | €171.82 Million | €9.13 Billion | ▲ +2.6 pp |
| 2015 | 58.7% | €5.17 Billion | €5.14 Billion | €27.59 Million | €8.81 Billion | ▼ -4.2 pp |
| 2014 | 62.9% | €5.13 Billion | €5.05 Billion | €76.60 Million | €8.15 Billion | ▼ -2.7 pp |
| 2013 | 65.6% | €4.98 Billion | €4.96 Billion | €19.74 Million | €7.60 Billion | — |